Catalent, Inc. (CTLT)
NYSE: CTLT · Real-Time Price · USD
59.77
+0.77 (1.30%)
Nov 21, 2024, 12:44 PM EST - Market open
Catalent Employees
Catalent had 17,800 employees as of June 30, 2023. The number of employees decreased by 1,200 or -6.32% compared to the previous year.
Employees
17,800
Change (1Y)
-1,200
Growth (1Y)
-6.32%
Revenue / Employee
$248,427
Profits / Employee
-$23,202
Market Cap
10.85B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 17,800 | -1,200 | -6.32% |
Jun 30, 2022 | 19,000 | 1,700 | 9.83% |
Jun 30, 2021 | 17,300 | 3,400 | 24.46% |
Jun 30, 2020 | 13,900 | 1,600 | 13.01% |
Jun 30, 2019 | 12,300 | 1,600 | 14.95% |
Jun 30, 2018 | 10,700 | -100 | -0.93% |
Jun 30, 2017 | 10,800 | 1,600 | 17.39% |
Jun 30, 2016 | 9,200 | 500 | 5.75% |
Jun 30, 2015 | 8,700 | 400 | 4.82% |
Jun 30, 2014 | 8,300 | 0 | - |
Sep 30, 2013 | 8,300 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Encompass Health | 37,761 |
Smith & Nephew | 19,081 |
AptarGroup | 13,800 |
Exact Sciences | 6,600 |
Medpace Holdings | 5,900 |
Globus Medical | 5,000 |
Bio-Techne | 3,050 |
Sarepta Therapeutics | 1,314 |
CTLT News
- 8 days ago - EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 bln deal - Reuters
- 16 days ago - Catalent misses Q1 revenue estimates ahead of $16.5 bln deal close with Novo Holdings - Reuters
- 16 days ago - Catalent, Inc. Reports First Quarter Fiscal 2025 Results - Business Wire
- 17 days ago - EU antitrust regulators to decide on Novo's Catalent buy by Dec. 6 - Reuters
- 4 weeks ago - Roche comes out against clearing takeover of drug manufacturer Catalent - Reuters
- 4 weeks ago - Catalent CEO to remain in charge of contract drugmaker after Novo Holdings' buyout - Reuters
- 4 weeks ago - Catalent Issues Open Letter to Customers Regarding Pending Acquisition by Novo Holdings - Business Wire
- 4 weeks ago - Consumer groups ask FTC to block Novo Holdings-Catalent deal - Reuters